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(NSTEMI) vs. ST elevation MI (STEMI) MACE was similar for HRPR and
responders [4/113 (3.5%) vs. 6/163 (3.7%), respectively, pNS, for UA/NSTEMI and
1/35 (2.8%) vs. 2/60 (3.3%), respectively, pNS, for STEMI]. The 30 day incidence of
stent thrombosis was only 1 in the HRPR group and was related to medication
noncompliance.
Conclusions: Adjusting anti-platelet therapy for ACS patients on the basis of Veri-
fyNow testing results in low and equivalent MACE at 30 days after PCI, for initial
anti-platelet responders and HRPR patients switched to more effective therapy.
Atherectomy Devices
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Background: In recent years, several modifications in rotational atherectomy technique
have been developed. However, no study has evaluated the clinical outcomes of rotational
atherectomy prior to- and during the DES era.
Methods: All patients who underwent rotational atherectomy for complex coronary
lesions in our center prior to- and during the current DES era were retrospectively
enrolled. Baseline clinical and angiographic characteristics were compared; as were
procedural success and clinical outcomes at 1 year.
Results: Among the 215 patients included in the analysis, 74 (22%) were from the
pre-DES era while 141 (78%) were from the DES era. More patients in the DES era
group had history of peripheral vascular disease and hypertension (25% vs. 15.4%,
p0.04) and (96% vs. 77.5%, p0.001), retrospectively. Procedural success was higher in
DES era group (99.6% vs. 93.6%, 0.001); furthermore the DES era group was
associated with a lower in-hospital coronary artery bypass surgery (0.5% vs. 4%, p0.03),
dissection rate (0.0% vs. 2.3%, p0.04), abrupt closure (0.0% vs. 3.8%, p0.006).
One-year follow up showed a lower rate of death in the DES era group (5.0% vs. 14.6%,
p0.04).
Conclusion: In the DES era, rotational atherectomy has become safer and effective
procedure for complex coronary lesions.
Variable DES Era(n141) Pre-DES Era(n74) p Value
6 months follow-up
TVR MACE 14 (9.5%) 7 (11.1%) 0.72
TLR MACE 13 (8.8%) 7 (11.1%) 0.60
Death 6 (4.1%) 6 (9.5%) 0.19
TLR 7 (4.9%) 1 (1.6%) 0.44
TVR 8 (5.6%) 1 (1.6%) 0.28
QWMI 0 0 0.00
NQWMI 3 (2.2%) 0 0.57
ST 0 0 0.00
1 year follow-up
TVR MACE 21 (15%) 12 (25%) 0.11
TLR MACE 20 (14%) 12 (25%) 0.08
Death 7 (5%) 7 (14.5%) 0.04
TLR 13 (9.6%) 5 (11%) 0.77
TVR 14 (10.4%) 5 (11%) 1.00
QWMI 0 0 0.00
NQWMI 3 (2.2%) 0 0.57
ST 0 0 0.00
TVR target vessel revascularization; MACE major adverse cardiovascular event; TLR target
lesion revascularization; QWMI Q-wave myocardial infarction; NQWMI non Q-wave myocar-
dial infarction; ST stent thrombosis; Maxmaximum.
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Introduction: Percutaneous coronary intervention (PCI) of heavily calcified
lesions is a challenge for the interventional cardiologist. The aim of this study was
to investigate the immediate and long-term outcome of patients (pts) treated with
rotational atherectomy (RA).
Methods: All consecutive pts treated by PCI with RA at our center between 09/1998-
12/2011 entered in a database and were analyzed retrospectively. Clinical indication were
Acute Coronary Syndrome in 148 pts (52%). Data of early and late (mean follow-up
6952 months) major adverse cardiac events (MACE) included cardiac death, stroke,
acute myocardial infarction (AMI) and target lesion failure (TLF).
Results: A total of 283 pts (306 lesions) were included. Mean age was 7010, 80% were
male, 33% diabetic and 42% had chronic renal failure (CRF). 234 pts (83%) had
multivessel disease. According to ACC/AHA classification, 79% were type C. Mean
vessel diameter was 3.30.4 mm. After RA, cutting-balloon (CB) was used in 35% of
cases. Drug eluting stents (DES) were implanted in 44% of pts, bare metal (BMS) in 47%.
Pts were divided in two groups, according to Burr/Artery Ratio (BAR): group 1 (BAR
0.5 plus cutting-balloon use, 64%) and group 2 (BAR0.5 with or without cutting-
balloon, 31%). Procedural success was 96.6%, early mortality 1.4%, stroke or TIA 1.4%,
acute renal injury 5.3%. CK-MB rise 5x Upper Limit value occurred in 2.8% of pts and
vessel perforation in 1.4%. CRF (95% CI,1.2-1.7,p0.03), Peripheral Artery Disease (CI
95%1.6-6.6,p0.006), no use of cutting-balloon in lesion treated with BAR  0.5 (CI
95% 1.2-42.3, p0.0001) and transient/persistent slow-no flow (CI 95% 1.5-9.8,
p0.01) were independent predictor of MACEs. Persistent no-slow flow occurred










significantly less in group 1 (0.5% vs 1.9%,p0.01), like as coronary perforation (0.5% vs
3.9%, p0.001) and acute stent thrombosis (2.4 vs 0%,p0.01). The incidence of
MACE was significantly lower in group 1 at 6 months (5.4% vs 9.8%,p0.03), 1 year
(7.1% and 12.2%,p0.001) and 5 years (17.7% vs 31.3%, p0.001).
Conclusions: RA is maybe a safe technique in the treatment of complex lesions, with
high success rate. A “minimalistic approach” using small BAR and the CB (Rota-Cut
technique) followed by DES implantation, seems promising in reducing complications




Treatment Of Coronary Bifurcation Lesions: Stentcovering Of The Side Branch With
And Without PCI Of The Side Branch - A Retrospective Analysis Of All Consecutive
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Background: Treatment of coronary bifurcation lesions is a complex issue.
Methods: This retrospective observational study included patients (pts) who underwent
PCI of a de novo coronary bifurcation lesion between January 2008 - August 2011. We
included all consecutive patients where the side branch had been covered with a stent. Pts
with ACS/cardiogenic shock were not excluded.
Two different methods were compared: group A represented patients undergoing a
simple strategy without any treatment of the side branch (SB). Group B consisted of
patients where the SB was treated (PCI and/or stenting).
For the treatment of bifurcation lesions we used the concept of “provisional stenting”.
Indications for the treatment of the SB included residual stenosis  50 %, and a TIMI
flow reduction  2.
Results: We performed 1688 PCI during the study period, and of these 138 pts had a
bifurcation lesion. We excluded pts with an in-stent-restenosis and pts who had been
treated with a drug-coated balloon. The remainder of the population constituted our study
group (n 98) which was divided into group A (n64, 65.3 %) and group B (n34, 34.7
%). Mean FU duration was 14.1 (group A) vs 12.3 (group B, pns) months.
Results: basicdata
Mean age (years) was 70.3 yrs (group A) vs. 67.0 yrs (group B, pns), 65.6 % were men
(group A) vs. 70.6 % (group B, pns). NSTEMI/STEMI was present in 54.7 % (group
A) vs. 41,2 % (group B, pns).
Results: procedural characteristics
Primary stenting was done in 29.7 % (group A) vs. 23.5 % (group B, pns), drug-eluting
stents were used in 56.3 % (group A) vs. 50.0 % (group B, pns). Duration of x-raying
(min, group A vs group B) and the amount of contrast medium (ml) were both
significantly lower in group A: 18.1 min vs 20.1 min and 225.8 ml vs 307.4 ml (p0.02
and p  0.001, respectively).
Procedural results
Final TIMI flow III inside the MB was reached in 98.4 % (group A) vs. 97.1 % (group B,
pns), while inside the SB it was reached in 84.4 % vs. 94.1 % (p ns, group A vs group B).
Results: FUdata
Target lesion revascularization (TLR: Re-PCI of the lesion, definite stent thrombosis or
CABG related to the target lesion) and target vessel revascularization (TVR) was seen in
15.9 % (group A) vs 32.4 % (group B, p0.07), while cardiac death was observed in 7.9
% (group A) vs 14.7 % (group B, p0.3). A survey of all MACE in both groups (TLR
plus TVR plus cardiac death) revealed the following distributions: 23.8 % (group A) vs.
47.1 % (group B, p0.02).
Conclusion: In patients with coronary bifurcation lesions, a simpler strategy without
SB-PCI has a significantly lower MACE rate.
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Aim: The purpose of this study was to determine the long-term (up to 4 years) results of
endovascular treatment of patients with true coronary artery bifurcation lesions.
Methods: This study enrolled 240 patients. Inclusion criteria were: the presence of true
coronary artery bifurcation lesion; side branch diameter more than 2 mm; III and IV
functional class of angina. During the first phase of the study all bifurcational lesions were
treated with provisional T stenting technique. During the second phase of the study
treatment strategy of bifurcational stenting was discussed for every patient prior to
intervention. Only drug eluting stents were used. Endpoints of the study were determined
as the presence of major adverse cardiac events.
Results: 70 patients were enrolled during the I phase of the study. In 9 (12,8%) patients
provisional T stenting technique was unsuccessful and “two stent” strategy were used.
Technical success of the procedure was observed in 100% of patients. The incidence of
death during the hospitalization period was 0%. Risk factors that leads from provisional
T stenting strategy to “two stent” strategy were: angle of bifurcation less than 700, length
of the side branch lesion more than 2,1 mm, diabetes mellitus, calcinosis of the main and
side branch, side branch diameter more than 2,3 mm, age more than 61 years. During the
second phase of the study all patients were divided into two groups. I group consists of 132
patients in whom “one stent” strategy was used to treat bifurcational lesion. “Two stent”
strategy was used in 38 patients. Survival rate was 97,47% and the incidence of myocardial
infarction was 6,25% in the long term follow up period. The rate of restenosis was 2,08%
in the side branch and 0% in the main branch. Definite late stent thrombosis was observed
in 0,8% of patients. The rate of MACE didn’t differ significantly between the “one stent”
strategy and “two stent” strategy (10,64% and 5,24%, 0,172).
Conclusion: The results of this study showed that differentiated approach used for
selection and treatment of patients with true coronary artery bifurcational lesions leads to
significant increase of clinical success in the long term follow up period.
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Background: Some study reports that the rate of major adverse cardiac events (MACE)
rises when final kissing ballooning (FKB) was performed in the single stent strategy.
However, the effects of FKB in everolimus-eluting stent (EES) implantation are still
unclear.
Purpose: To clarify the prognosis of patients who were implanted EES at bifurcation
lesions.
Methods: The case of bifurcation lesions with single stent strategy was investigated by
Tokyo-MD PCI study, a multicenter study including 22 institute around Kanto region.
Rate of target lesion revascularization (TLR) and MACE (any cause death, myocardial
infarction, TLR, stent thrombosis, and cerebral infarction) were analyzed.
Results: 184 bifurcation lesions treated by single EES were available. 49 lesions were
treated with FKB (FKB group), and 135 were treated without FKB (none-FKB group).
FKB group had significantly high rate of left main bifurcation lesions and low rate of left
circumflex lesions. Other clinical characteristics were similar in both groups. Mean follow
up term were 455254 days. Cumulative incidence of TLR in main branch was 6.2% in
FKB group and 6.3% in none-FKB group at 2 years follow up (p1.0). Incidence of
MACE was 8.5% in FKB group and 11.5% in none-FKB group (p0.7).
Conclusion: FKB group has showed no inferior rate of TLR and MACE despite of high
left main bifurcation rate when EES was implanted.
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